Current treatment of in-stent restenosis

Citations of this article
Mendeley users who have this article in their library.


Management of patients with in-stent restenosis (ISR) remains an important clinical problem. Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment of DES-ISR is particularly challenging. ISR mainly results from aggressive neointimal proliferation, but recent data also suggest that neoatherosclerosis may play an important pathophysiological role. Intracoronary imaging provides unique insights to unravel the underlying substrate of ISR and may be used to guide repeated interventions. In this paper, we systematically reviewed clinical trial data with currently available therapeutic modalities, including DES and drug-coated balloons, in patients presenting with ISR within bare-metal stents or DES. © 2014 by the American College of Cardiology Foundation.




Alfonso, F., Byrne, R. A., Rivero, F., & Kastrati, A. (2014, June 24). Current treatment of in-stent restenosis. Journal of the American College of Cardiology. Elsevier USA.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free